News and Press Releases

ProPharma Names Dawn Sherman Chief Executive Officer

Veteran life sciences and biopharmaceutical industry executive previously served as ProPharma CEO 1 October 2024 -- North Carolina, US -- ProPharma, the leading global provider of regulatory, clinical, and compliance...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: October 1, 2024

107 West Hargett St. Raleigh, NC 27601

Tracey Marantal Joins Worldwide Clinical Trials as President, Oncology Business Unit

Proven clinical operations leader joins global CRO to lead high-performing therapeutic team and drive strategy for growing oncology portfolio 24 September 2024 -- North Carolina, US -- Tracey Marantal has...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024

600 Park Offices Drive Suite 200 Research Triangle Park, NC 27709 USA

Tiziana Life Sciences Announces $4 Million Grant Awarded by National Institutes of Health to Study Anti-CD3 in Alzheimer’s Disease

19 September 2024 -- New York, US -- Tiziana Life Sciences, Ltd, a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3...

Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: September 19, 2024

Tiziana Life Sciences 14/15 Conduit Street London W1S 2XJ United Kingdom

AC Immune Receives Second Milestone Payment Following Progress in Phase 2b ReTain Trial of ACI-35.030 in Preclinical Alzheimer’s Disease

Prescreening rate of Phase 2b ReTain trial triggers clinical development milestone payment in September Potentially registrational trial is targeting enrollment of approximately 500 participants with pre-symptomatic AD FDA Fast Track...

Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 17, 2024

EPFL Innovation Park-Building B 1015 Lausanne / Switzerland

ILC Therapeutics completes £2.5m financing and bolsters C-suite

Owain Millington appointed CEO, Julie Bailey appointed CFO and Dawn Firmin appointed COO Financing to support pre-clinical development of ILCT’s two lead assets 11 September 2024 -- Glasgow, UK --...

Category:
Posted: September 13, 2024

75 King William Street London EC4N 7BE

Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors

Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...

Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024

Babraham Research Campus Cambridge CB22 3AT United Kingdom

COREX Logistics Appoints New CEO to Expand Global Growth

Clinical trial and pharmaceutical logistics specialists COREX Logistics have announced the appointment of Steve Healy as its new CEO of the organisation. Healy, COREX Logistics’ former Vice President of Business...

Category: Clinical Trials, Logistics, Other
Posted: July 30, 2024

Suite 40, The Guinness Enterprise Centre, Taylors Lane, Dublin 8, Ireland

Broken String Biosciences appoints Steve Becker as Chief Commercial Officer

Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...

Category: BioManufacturing
Posted: July 24, 2024

Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR

Cherwell appoints new director of operations following retirement of Martyn Young

Newly appointed Andy Charteris to help company focus on continuous improvement initiatives 18 July 2024 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert, is pleased to announce the appointment...

Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: July 18, 2024

Launton Business Centre Murdock Rd, Bicester OX26 4XB

Optibrium Appoints James Halle as chief commercial officer

Key appointment brings extensive software commercial experience to drive global growth 16 July 2024 – Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery...

Category: Drug Discovery
Posted: July 16, 2024

Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK

Asceneuron Secures $100m Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases

Financing led by Novo Holdings, including new investment from EQT Life Sciences – LSP Dementia Fund, OrbiMed and SR One with participation from existing investors M Ventures, Sofinnova Partners, GSK...

Category: Biotechnology, Clinical Trials, Other
Posted: July 16, 2024

Asceneuron SA, EPFL Innovation Park, Bâtiment B, CH-1015 Lausanne, Switzerland

Signant Health Appoints 20-Year Life Sciences Veteran Paul Richmond to executive leadership team as chief commercial officer

15 July 2024 – Pennsylvania, US – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Paul Richmond as chief commercial officer. A...

Category: Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024

4000 Chemical Road Suite 300 Plymouth Meeting, PA 19462

Mogrify appoints Dr Jonathan Appleby as chief scientific officer

Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...

Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024

25 Cambridge Science Park Milton Rd, Milton, Cambridge CB4 0FW

Pascal Piedbois MD PhD joins One2Treat as chief medical officer to advance patient-centric innovation in clinical trial design and market access

One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments.  9 July 2024 -- Brussels, Belgium -- In this...

Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 10, 2024

Rue Emile Francqui, 1-1435 Mont-Saint-Guibert, Belgium

Clinigen appoints Fernando Ballester as Chief Financial Officer

2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando,...

Category: Other, Pharmaceutical
Posted: July 2, 2024

25 Bedford Square Bloomsbury London WC1B 3HH